The table below shows KESTRA MEDICAL TECHNOLOGIES, LTD.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q4 2025
Q3 2025
Q2 2025
Q4 2024
Q3 2024
Q2 2024
Revenue
$24.55M
$22.57M
$19.37M
$15.09M
$14.71M
$12.78M
Cost of revenue
$11.65M
$11.14M
$10.52M
$8.54M
$8.88M
$8.58M
Gross profit
$12.91M
$11.42M
$8.85M
$6.55M
$5.83M
$4.20M
R&D
$4.97M
$4.88M
$4.00M
$3.35M
$3.51M
$3.40M
KMTS annual revenue (10-K history)
KESTRA MEDICAL TECHNOLOGIES, LTD. reported annual revenue of $59.81M for fiscal year 2025. That is up 115.1% from $27.81M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.